Jacobson Pharma reports stable share capital and options in November

Jacobson Pharma Corporation Limited, an equity issuer, submitted its monthly return on movements in securities for the period ending November 30, 2025. The company's authorized share capital remained stable at 5,000,000,000 ordinary shares, each with a par value of HK$0.01, totaling HK$50,000,000.

For the same period, the total number of issued ordinary shares also held steady at 2,000,221,000. There were no increases or decreases in issued shares, nor were there any movements in treasury shares. The company's Share Option Scheme, adopted on August 30, 2016, also showed no new share options issued or exercised during the month, with 138,000,000 shares remaining available for future grants under the scheme.

The report, dated December 1, 2025, confirmed that all regulatory and listing requirements have been met, and no new funds were raised from the exercise of options during the month.